You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Dow
Merck
McKesson
Harvard Business School

Last Updated: June 6, 2020

DrugPatentWatch Database Preview

VISKEN Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Visken, and what generic alternatives are available?

Visken is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in VISKEN is pindolol. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the pindolol profile page.

US ANDA Litigation and Generic Entry Outlook for Visken

A generic version of VISKEN was approved as pindolol by MYLAN PHARMS INC on September 3rd, 1992.

  Start Trial

US Patents and Regulatory Information for VISKEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis VISKEN pindolol TABLET;ORAL 018285-001 Sep 3, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Novartis VISKEN pindolol TABLET;ORAL 018285-002 Sep 3, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Dow
Merck
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.